EMD Millipore And Associates Of Cape Cod, Inc. Launch Collaborative Educational Program For QC Microbiology Professionals
- Three-day course focuses on bioburden, endotoxin and sterility testing quality control methods
- Attendees will explore practical applications and learn techniques to ensure high product quality and regulatory compliance
- Courses launch in July 2012 and are offered throughout the US and Canada on an ongoing basis
EMD Millipore, the Life Science division of Merck KGaA of Germany, recently announced a partnership with Associates of Cape Cod, Inc. (ACC) to offer a series of educational programs for quality control and laboratory professionals entitled "BEST: QC Microbiology Training."
Initial dates and locations are:
July 17 – 19, Toronto Canada
September 25 – 27, Philadelphia, PA
October 16 – 18, Research Triangle Park, NC
November 6 – 8, San Diego, CA
The courses will focus on three critical in-process and product release quality control tests: Bioburden, Endotoxin and Sterility Testing (BEST) and will be offered throughout the US and Canada. Consisting of classroom presentations and laboratory application demonstrations, the BEST program will provide an overview of relevant methods and techniques in each area as used by pharmaceutical, biotechnology and medical device organizations. Upon completion of the program, laboratory professionals will better understand the methods, techniques and practical applications which help ensure product quality and regulatory compliance. Basic laboratory skills are assumed as a prerequisite for participation in BEST courses.
"The collaboration with ACC brings together their leading endotoxin detection experience with our deep knowledge of quality control testing," said Roland Heinrich, Head of EMD Millipore's BioMonitoring Business Unit. "The combined expertise of our organizations has enabled us to create a unique educational program that will help laboratory professionals broaden and refine their QC microbiology skills."
"ACC has long been committed to providing laboratories with effective endotoxin detection products and services," said A.J. Meuse, ACC's President and CEO. "We are excited to join forces with EMD Millipore to offer a seminar that covers the broad spectrum of microbiology quality control techniques and will help QC professionals develop a deeper understanding of how to ensure product quality and compliance."
For more information, customers can contact either Tricia Griffiths at Tricia.Griffiths@merckgroup.com or James Spitzer at JSpitzer@acciusa.com or visit http://www.millipore.com/process_monitoring/cp1/bestqctraining
About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany
About Associates of Cape Cod, Inc.
Associates of Cape Cod, Inc. (ACC), is one of the world's largest manufacturers of products developed to detect and quantify Gram-negative bacterial endotoxins and (1→3)-β-D-glucans. Our products are used worldwide by leading pharmaceutical and medical device companies to ensure the safety of their parenteral drugs, biological products and medical devices. ACC's goal is to provide the best products and services, as well as the best technical support and customer service, to enhance the productivity and efficiency of all customers. ACC is ISO 13485:2003 certified, and its laboratories are FDA Inspected and DEA Licensed and the Beacon Diagnostics® laboratory is CLIA certified.
ACC's corporate headquarters are located in East Falmouth, Massachusetts with offices in the UK and Germany. Founded in 1974, ACC was the first to be licensed by the FDA to manufacture LAL for use as a quality control test for endotoxin detection in the pharmaceutical and medical device markets. Over the years, ACC has grown to be an internationally recognized leader in endotoxin detection, with a distribution network servicing over 80 countries.
SOURCE: Associates of Cape Cod, Inc.